Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole DDI study with CHF10196 in healthy males
NCT07683793Phase 1Not yet recruiting
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Oct 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of florensocatib, sponsored by Chiesi Farmaceutici S.p.A. Primary endpoints: Area Under the Curve from Time Zero to Infinity, Area Under the Curve from Time Zero to Last Quantifiable Concentration and 1 more. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
florensocatib
Beyond the preview
Go deeper on NCT07683793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07683793.